 |
 |
 |
 |
 |
 |
 |
 |
-
BROWSE TOPICS IN CLINICAL MANAGEMENT:
Antiretroviral Therapy- Complications of HIV/HAART
- Research & Development
- Clinical Trials
- Quality of Life & Patient Care
Antiretroviral Therapy
Metabolic Complications: Research
See also: Lipodystrophy Basics
2001
- Metabolic Complications of HIV Disease (December 18, 2001)
In 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2001), from The Body PRO - Select HIV Protease Inhibitors Alter Bone and Fat Metabolism In Vitro (December 16, 2001)
In 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2001), from The Body PRO - Triglyceride Increase Can Predict Lipodystrophy in HIV Patients Under HAART (December 16, 2001)
In 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2001), from The Body PRO - Associations Between Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Use and HIV-Associated Lipodystrophy Syndrome (HALS) in the Dagna-LipART Cohort Study (October 29, 2001)
In 8th European Conference on Clinical Aspects and Treatment of HIV-Infection, from The Body PRO - Rise in HDL Cholesterol Associated With Nevirapine Containing Antiretroviral Therapy in HIV-1 Infected Patients Is Sustained Over 48 Weeks of Treatment (October 29, 2001)
In 8th European Conference on Clinical Aspects and Treatment of HIV-Infection, from The Body PRO - Switching From PI-Based to NNRTI-Based Regimens: Clinical and Metabolic Outcomes (October 28, 2001)
In 8th European Conference on Clinical Aspects and Treatment of HIV-Infection, from The Body PRO - The Impact of First Line Therapies on Lipid Metabolism: The FRAMS Data (October 28, 2001)
In 8th European Conference on Clinical Aspects and Treatment of HIV-Infection, from The Body PRO - HIV-Positive Individuals and Fat Redistribution: Diet Modification May Be the Key (October 1, 2001)
To read PDF, click here
In STEP Ezine, from Seattle Treatment Education Project - Growth Hormone Used to Treat Humps and Excess Fat (August 21, 2001)
From Canadian AIDS Treatment Information Exchange - Carnitine for High Triglycerides (July 31, 2001)
From Canadian AIDS Treatment Information Exchange - Insulin Resistance in HIV Lipodystrophy Syndrome (July 2001)
In Body Positive, from Body Positive - Risk of Lipodystrophy in HIV-1-Infected Patients Treated with Protease Inhibitors: A Prospective Cohort Study (July 2001)
In Body Positive, from Body Positive - The Phenomena Formerly Known as Lipodystrophy (March 22, 2001)
Report from the 8th Conference on Retroviruses and Opportunistic Infections.
In STEP Ezine, from Seattle Treatment Education Project - Lipodystrophy Update: The Continuing Saga (March 2001)
To read PDF, click here
In Project Inform Perspective, from Project Inform - ACTG 5056: Metabolic Status and Cardiovascular Disease Risk for a Cohort of HIV-1-Infected Persons Durably Suppressed on an Indinavir-Containing Regimen (ACTG 372A) (February 7, 2001)
In The 8th Conference on Retroviruses and Opportunistic Infections, from The Body PRO - An Open Randomized Study on the Replacement of HIV-1 Protease Inhibitors by Efavirenz in Chronically Suppressed HIV-1-Infected Patients with Lipodystrophy (February 7, 2001)
In The 8th Conference on Retroviruses and Opportunistic Infections, from The Body PRO - Does Race Protect an Asian Population from Developing Lipodystrophy in HIV-Infected Individuals on HAART? (February 7, 2001)
In The 8th Conference on Retroviruses and Opportunistic Infections, from The Body PRO - Long-Term Efficacy and Tolerance of Switching the Protease Inhibitor for Non-Nucleoside Reverse Transcriptase Inhibitors: A 52-Week, Multicenter, Prospective Study (February 7, 2001)
In The 8th Conference on Retroviruses and Opportunistic Infections, from The Body PRO - Metabolic and Clinical Evaluation of Lipodystrophy Syndrome (LD) in HIV-1-Infected Adults Receiving Initial HAART with or without a Protease Inhibitor (PI): 48-Week Data from the CNAF3007 Study (February 7, 2001)
In The 8th Conference on Retroviruses and Opportunistic Infections, from The Body PRO - Metabolic Complications of HIV-1 Disease (February 7, 2001)
In The 8th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
  |
  |